Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NextGen Invent provides advanced technology consulting and services specializing in artificial intelligence, data science, analytics, automation, cloud solutions, and digital transformation. The company works with healthcare organizations—including hospitals and life sciences companies—by building custom software solutions such as clinical decision support systems and AI-driven tools to accelerate drug discovery. However, it does not itself discover or commercialize drugs or medical devices.
Their expertise includes enabling clients to use AI for tasks like identifying new drug candidates more efficiently but they are a service provider rather than a product/drug developer.
They have been recognized by Gartner for their work in cognitive automation platforms.
Key case studies include supporting rapid scaling of point-of-care medical imaging AI companies and developing SaaS products that improve operational efficiency in healthcare settings.
The company has grown rapidly with an estimated $41.2M annual revenue and over 250 employees globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NextGen Invent.